Filing Details

Accession Number:
0001325812-10-000025
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-06-18 13:00:00
Reporting Period:
2010-06-17
Filing Date:
2010-06-18
Accepted Time:
2010-06-18 17:03:29
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1178670 Alnylam Pharmaceuticals Inc. ALNY Pharmaceutical Preparations (2834) 770602661
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1332911 L James Vincent 300 Third Street
Cambridge MA 02142
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-06-17 1,333 $15.70 8,667 No 4 S Direct
Common Stock Disposition 2010-06-18 8,667 $15.16 0 No 4 S Direct
Common Stock Acquisiton 2010-06-18 12,100 $7.02 12,100 No 4 M Direct
Common Stock Disposition 2010-06-18 12,100 $15.19 0 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Non-Qualified Stock Option (right to buy) Disposition 2010-06-18 12,100 $0.00 12,100 $7.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2015-07-12 No 4 M Direct
Footnotes
  1. The stock option vested as to one third of the shares on each of the first, second and third anniversaries of the grant date.